Citation: | Wang Guangce, Wang Suogang, Chen Zhu, et al. Study on clinicopathologic characteristics and individualized immunotherapy of antibody-mediated rejection after renal transplantation[J]. ORGAN TRANSPLANTATION, 2015, 6(4): 224-229. doi: 10.3969/j.issn.1674-7445.2015.04.004 |
[1] |
Alvarez-Márquez A, Aguilera I, Gentil MA, et al. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies[J]. Transplantation, 2009, 87(1):94-99. doi: 10.1097/TP.0b013e31818bd790
|
[2] |
孙启全, 季曙明.抗体介导的移植肾排斥[J].肾脏病与透析肾移植杂志, 2006, 15:282-289. http://d.wanfangdata.com.cn/Periodical/szbytxsyzzz200603017
Sun QQ, Ji SM. Antibody-mediated rejection[J]. Chin J Nephrol Dial Transplant, 2006, 15:282-289. http://d.wanfangdata.com.cn/Periodical/szbytxsyzzz200603017
|
[3] |
Seveso M, Bosio E, Ancona E, et al. De novo anti-HLA antibody responses after renal transplantation:detection and clinical impact[J]. Contrib Nephrol, 2009, 162:87-98. http://www.ncbi.nlm.nih.gov/pubmed/19001816
|
[4] |
Melk A, Schmidt BM, Braun H, et al. Effects of donor age and cell senescence on kidney allograft survival[J]. Am J Transplant, 2009, 9(1):114-123. http://www.ncbi.nlm.nih.gov/pubmed/19133932
|
[5] |
Randhawa PS, Schonder K, Shapiro R, et al. Polyomavirus BK neutralizing activity in human immunoglobulin preparations[J]. Transplantation, 2010, 89(12):1462-1465. doi: 10.1097/TP.0b013e3181daaaf1
|
[6] |
Wang D, Xu TZ, Chen JH, et al. Factors influencing second renal allograft survival:a single center experience in China[J]. Transpl Immunol, 2009, 20(3):150-154. doi: 10.1016/j.trim.2008.09.010
|
[7] |
Sis B, Mengel M, Haas M, et al. Banff' 09 meeting report:antibody mediated graft deterioration and implementation of Banff working groups[J].Am J Transplant, 2010, 10(3):464-471. doi: 10.1111/ajt.2010.10.issue-3
|
[8] |
Kidney Disease:Improving Global Outcomes(KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009, 9(Suppl 3):S1-S155. http://kdigo.org/home/guidelines/care-of-the-kidney-transplant-recipient/
|
[9] |
Jirasiritham S, Khunprakant R, Techawathanawanna N, et al. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation:a case report[J]. Transplant Proc, 2010, 42(3):987-989. doi: 10.1016/j.transproceed.2010.03.018
|
[10] |
Obeidat MA, Luyckx VA, Grebe SO, et al. Post-transplant nuclear renal scans correlate with renal injury biomarkers and early allograft outcomes[J].Nephrol Dial Transplant, 2011, 26(9):3038-3045. doi: 10.1093/ndt/gfq814
|
[11] |
Günther OP, Lin D, Balshaw RF, et al. Effects of sample timing and treatment on gene expression in early acute renal allograft rejection[J].Transplantation, 2011, 91(3):323-329. doi: 10.1097/TP.0b013e3182029b16
|
[12] |
Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report:inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions[J]. Am J Transplant, 2014, 14(2):272-283. doi: 10.1111/ajt.12590
|
[13] |
王仁定, 王慧萍, 吴建永, 等.急性细胞性排斥伴补体裂解片断C4d沉积对移植肾预后的影响[J].器官移植, 2010, 1(3):141-143, 165. http://www.organtranspl.com/browse/detail/qkid/33/id/404
Wang RD, Wang HP, Wu JY, et al. Effect of acute cellular rejection with C4d deposition on renal allograft survival[J].Organ Transplant, 2010, 1(3):141-143, 165. http://www.organtranspl.com/browse/detail/qkid/33/id/404
|
[14] |
Singh N, Pirsch J, Samaniego M. Antibody-mediated rejection:treatment alternatives and outcomes[J].Transplant Rev, 2009, 23(1):34-46. doi: 10.1016/j.trre.2008.08.004
|
[15] |
孙启全, 黎磊石, 唐政, 等.他克莫司联合霉酚酸酯治疗肾移植术后早期难治性急性体液性排斥的疗效[J].肾脏病与透析肾移植杂志, 2006, 1(15):12-17. http://www.cnki.com.cn/Article/CJFDTOTAL-SZBY200601002.htm
Sun QQ, Li LS, Tang Z, et al. The efficacy of FK506 and mycophenolate mofetil rescue therapy for acute humoral rejection of kidney transplants[J]. Chin J Nephrol Dial Transplant, 2006, 1(5):12-17. http://www.cnki.com.cn/Article/CJFDTOTAL-SZBY200601002.htm
|